FROOME ASKED TO EXPLAIN ADVERSE SAMPLE

FROOME ASKED TO EXPLAIN ADVERSE SAMPLE

FOUR-TIME TOUR DE FRANCE WINNER CHRIS FROOME HAS SAID HE FOLLOWED MEDICAL ADVICE BY TAKING AN INCREASED DOSAGE OF ASTHMA MEDICATION AT THE VUELTA A ESPANA.

 

Cycling's world governing body (UCI) has notified the Briton of an 'Adverse Analytical Finding" from a urine sample taken after Stage 18 of the race. The sample had double the permissible limit of Salbutamol, which is permitted as a legal asthma drug by the Word Anti-Doping Agency.

 

"It is well known that I have asthma and I know exactly what the rules are," the Team Sky rider, who won the Vuelta, said in a statement.

 

"I use an inhaler to manage my symptoms (always within the permissible limits) and I know for sure that I will be tested every day I wear the race leader's jersey.

 

"My asthma got worse at the Vuelta so I followed the team doctor's advice to increase my Salbutamol dosage. As always, I took the greatest care to ensure that I did not use more than the permissible dose."

 

The UCI said in a statement: "The analysis of the B sample has confirmed the results of the rider’s A sample and the proceedings are being conducted in line with the UCI Anti-Doping Rules".

Published: by Radio NewsHub
Start your relationship

If you are interested in receiving bulletins from Radio News Hub or would simply like to find out more please fill in the form below.

We aim to get back to you within 48 hours